Literature DB >> 3159818

A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562.

J H Phillips, L L Lanier.   

Abstract

A subpopulation of low density granular lymphocytes that express the natural killer (NK) cell-associated Leu-11 antigen (IgG Fc receptor) were stimulated directly by coculture with an NK-sensitive tumor cell, K562. T lymphocytes (Leu-11-) responded only weakly when cocultured with K562. The response of Leu-11+ cells apparently did not require exogeneous factors or accessory cells. The K562-activated cells retained expression of Leu-11 antigen, acquired activation antigens, and were highly cytotoxic against NK-sensitive and -insensitive tumor cells. Anti-IL-2 receptor monoclonal antibody minimally inhibited the activation of Leu-11+ cells by K562, but completely inhibited the phytohemagglutinin-induced activation of the Leu-11- cells from the same individual. Leu-11+ cells can be divided into Leu-7-11+ and Leu-7+11+ subpopulations using anti-Leu-7 antibody. These subsets were separated by two-color fluorescence-activated cell sorting and cocultured with K562. Proliferation by Leu-7-11+ cells was significantly greater than by Leu-11+7+ cells. Leu-7+11- granular lymphocytes and T lymphocytes (Leu-7-11-) typically proliferated only weakly when cocultured with K562. A proportion of the Leu-7-11+ cells acquired Leu-7 antigen after stimulation with K562, whereas the phenotype of Leu-7+11+, Leu-7+11-, and Leu-7-11- subsets was unaffected. These results demonstrate a developmental relationship between the Leu-7-11+ and Leu-7+11+ lymphocytes and suggest that Leu-7 antigen may be expressed late in the differentiation pathway of NK cells. The direct activation of highly purified Leu-11+ cells by coculture with K562 provides an in vitro model with which to study the activation and maturation of human NK cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159818      PMCID: PMC2187621          DOI: 10.1084/jem.161.6.1464

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  Distinction of anti-K562 and anti-allocytotoxicity in in vitro-stimulated populations of human lymphocytes.

Authors:  A Poros; E Klein
Journal:  Cell Immunol       Date:  1979-08       Impact factor: 4.868

2.  Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells.

Authors:  J K Seeley; G Masucci; A Poros; E Klein; S H Golub
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

3.  Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.

Authors:  R R Herberman; J R Ortaldo; G D Bonnard
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

4.  Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells.

Authors:  E Svedmyr; H Wigzell; M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

5.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

6.  Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity.

Authors:  T Timonen; J R Ortaldo; R B Herberman
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

7.  Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.

Authors:  M López-Botet; A Silva; J Rodríguez; M O de Landazuri
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

8.  Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies.

Authors:  J R Ortaldo; S O Sharrow; T Timonen; R B Herberman
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

9.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.

Authors:  T Timonen; J R Ortaldo; R B Herberman
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

10.  In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity.

Authors:  M Jondal; S Targan
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  34 in total

1.  Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells.

Authors:  N al Jarad; M Macey; S Uthayakumar; A C Newland; R M Rudd
Journal:  Br J Ind Med       Date:  1992-11

2.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Suchitra Pandey; Vanessa A York; Janice Arakawa-Hoyt; Hanspeter Pircher; Philip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

Review 3.  Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes.

Authors:  L L Lanier; J H Phillips
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

4.  Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation.

Authors:  J W Gratama; R A Langelaar; M A Oosterveer; J A van der Linden; A den Ouden-Noordermeer; A M Naipal; J W Visser; G C de Gast; H J Tanke
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

5.  Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.

Authors:  L Matera; R Foa; F Malavasi; G Bellone; A Funaro; F Veglia; D Santoli
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 6.  NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?

Authors:  Catharina H M J Van Elssen; Stefan O Ciurea
Journal:  Int J Hematol       Date:  2017-12-01       Impact factor: 2.490

7.  The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.

Authors:  Y Abe; M Miyake; T Miyazaki; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1990-01

8.  Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions.

Authors:  Kimberley A Stannard; Sébastien Lemoine; Nigel J Waterhouse; Frank Vari; Lucienne Chatenoud; Maher K Gandhi; Ludovic Martinet; Mark J Smyth; Camille Guillerey
Journal:  Blood Adv       Date:  2019-06-11

9.  Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.

Authors:  Hiroyuki Fujisaki; Harumi Kakuda; Noriko Shimasaki; Chihaya Imai; Jing Ma; Timothy Lockey; Paul Eldridge; Wing H Leung; Dario Campana
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

10.  A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia.

Authors:  Ji Yoon Lee; Sohye Park; Donghyun Curt Kim; Jae-Ho Yoon; Seung Hwan Shin; Woo-Sung Min; Hee-Je Kim
Journal:  J Clin Immunol       Date:  2013-02-13       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.